Cargando…
Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease
While bisphosphonates are indicated for prevention of skeletal-related events, radionuclide therapy is widely used for treatment of painful bone metastases. Combined radionuclide therapy with bisphosphonates has demonstrated improved effectiveness in achieving bone pain palliation in comparison to m...
Autores principales: | Rasulova, Nigora, Lyubshin, Vladimir, Arybzhanov, Dauranbek, Sagdullaev, Sh., Krylov, Valery, Khodjibekov, Marat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745627/ https://www.ncbi.nlm.nih.gov/pubmed/23961250 http://dx.doi.org/10.4103/1450-1147.113939 |
Ejemplares similares
-
Effectiveness of Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience
por: Rasulova, Nigora, et al.
Publicado: (2013) -
Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
por: Joob, Beuy, et al.
Publicado: (2014) -
Beyond Palliation: Therapeutic Applications of (153)Samarium-EDTMP
por: Wilky, Breelyn A., et al.
Publicado: (2013) -
Strategy for Bone Metastases Treatment in Patients with Impending Cord Compression or Vertebral Fractures: A Pilot Study
por: Rasulova, N., et al.
Publicado: (2011) -
Radionuclide Treatment with 153Sm-EDTMP is Effective for the Palliation of Bone Pain in the Context of Extensive Bone Marrow Metastases: A Case Report
por: Kairemo, Kalevi, et al.
Publicado: (2014)